Erschienen in:
01.10.2013 | Viewpoint
Par-4 prevents breast cancer recurrence
verfasst von:
Nikhil Hebbar, Tripti Shrestha-Bhattarai, Vivek M Rangnekar
Erschienen in:
Breast Cancer Research
|
Ausgabe 5/2013
Einloggen, um Zugang zu erhalten
Abstract
Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.